[CORT] Corcept Therapeutics Incorporated

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 8.12 Change: 0.21 (2.65%)
Ext. hours: Change: 0 (0%)

chart CORT

Refresh chart

Strongest Trends Summary For CORT

CORT is in the medium-term up 38% in 6 months. In the long-term up 449% in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Corcept Therapeutics Incorporated, a pharmaceutical company, is engaged in the discovery, development, and commercialization of drugs for the treatment of metabolic, psychiatric, and oncologic disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing?s syndrome, who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing mifepristone, an active ingredient in Korlym, which is in Phase III study for treatment of the psychotic features of psychotic depression; and in Phase I study for the treatment of triple-negative breast cancer. In addition, it discovers and develops three series of novel selective GR-II antagonists. The company has research and development agreements with Argenta D

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 72.68% Sales Growth - Q/Q12.07% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-46.21% ROE-210.77% ROI
Current Ratio2.85 Quick Ratio2.76 Long Term Debt/Equity0.77 Debt Ratio1.47
Gross Margin96.87% Operating Margin-58.27% Net Profit Margin-69.1% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities15.52 M Cash From Investing Activities-30 K Cash From Operating Activities-1.78 M Gross Profit9.8 M
Net Profit-4.83 M Operating Profit-4.03 M Total Assets48.22 M Total Current Assets44.19 M
Total Current Liabilities15.53 M Total Debt32.78 M Total Liabilities37.65 M Total Revenue10.1 M
Technical Data
High 52 week17.19 Low 52 week9.78 Last close14.36 Last change2.21%
RSI43.75 Average true range0.45 Beta0.99 Volume325.31 K
Simple moving average 20 days1.81% Simple moving average 50 days7.91% Simple moving average 200 days18.95%
Performance Data
Performance Week2.21% Performance Month8.05% Performance Quart34.58% Performance Half21.9%
Performance Year17.32% Performance Year-to-date7.49% Volatility daily1.61% Volatility weekly3.6%
Volatility monthly7.37% Volatility yearly25.52% Relative Volume267.92% Average Volume720.16 K
New High New Low

News

2019-12-04 07:43:58 | Why Corcept Therapeutics Incorporated's NASDAQ:CORT High P/E Ratio Isn't Necessarily A Bad Thing

2019-11-19 08:51:01 | Can The Uptrend Continue for Corcept Therapeutics?

2019-11-14 08:52:01 | Options Traders Expect Huge Moves in Corcept CORT Stock

2019-11-08 18:08:00 | Edited Transcript of CORT earnings conference call or presentation 7-Nov-19 10:00pm GMT

2019-11-08 10:31:03 | Corcept CORT Earnings Beat in Q3, Korlym Boosts Sales

2019-11-07 19:35:12 | Corcept Therapeutics CORT Surpasses Q3 Earnings and Revenue Estimates

2019-11-07 16:05:00 | Corcept Therapeutics Announces Third quarter 2019  Financial Results and provides corporate update

2019-11-04 06:51:47 | Is Corcept Therapeutics Incorporated NASDAQ:CORT A High Quality Stock To Own?

2019-10-31 16:05:05 | Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call

2019-10-31 10:33:02 | Analysts Estimate Corcept Therapeutics CORT to Report a Decline in Earnings: What to Look Out for

2019-10-27 14:04:38 | Did Hedge Funds Drop The Ball On Corcept Therapeutics Incorporated CORT ?

2019-10-14 10:10:02 | Why Corcept CORT is Poised to Beat Earnings Estimates Again

2019-10-09 06:11:42 | The Corcept Therapeutics NASDAQ:CORT Share Price Has Soared 368%, Delighting Many Shareholders

2019-10-02 18:20:00 | Shareholder Alert: Robbins Arroyo Announces Another Complaint Filed Against Corcept Therapeutics Incorporated CORT

2019-09-18 08:30:00 | Corcept Therapeutics Appoints Kimberly Park to Board of Directors

2019-09-16 10:43:12 | Corcept Therapeutics Incorporated NASDAQ:CORT: A Fundamentally Attractive Investment

2019-09-13 13:54:09 | 5 Health Care Stocks Gurus Are Buying

2019-08-31 09:31:01 | Corcept CORT Up 15.1% Since Last Earnings Report: Can It Continue?

2019-08-28 16:05:00 | Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome

2019-08-27 13:05:03 | Is Corcept Therapeutics Incorporated's NASDAQ:CORT CEO Overpaid Relative To Its Peers?

2019-08-05 09:18:01 | Corcept's CORT Earnings & Revenues Miss Estimates in Q2

2019-08-03 08:53:01 | Edited Transcript of CORT earnings conference call or presentation 1-Aug-19 9:00pm GMT

2019-08-03 00:18:12 | Corcept Therapeutics Incorporated CORT Q2 Earnings Call Transcript

2019-08-01 19:05:11 | Corcept Therapeutics CORT Q2 Earnings Beat Estimates

2019-08-01 16:05:00 | Corcept Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update

2019-08-01 08:00:42 | Does Corcept Therapeutics Incorporated NASDAQ:CORT Have A High Beta?

2019-07-25 16:05:00 | Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

2019-07-09 10:03:45 | Can We See Significant Insider Ownership On The Corcept Therapeutics Incorporated NASDAQ:CORT Share Register?

2019-06-19 12:41:52 | Corcept Therapeutics Incorporated NASDAQ:CORT: Poised For Long Term Success?

2019-06-08 09:30:01 | Corcept CORT Down 11.3% Since Last Earnings Report: Can It Rebound?

2019-06-01 11:37:25 | The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace

2019-05-30 13:21:31 | Is Corcept Therapeutics Incorporated's NASDAQ:CORT P/E Ratio Really That Good?

2019-05-28 08:05:00 | Corcept Therapeutics to Present Data from Phase 1/2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Solid Tumors at the American Society of Clinical Oncology Annual Meeting

2019-05-20 07:30:00 | Lawsuit for Investors in shares of Corcept Therapeutics Incorporated NASDAQ: CORT announced by Shareholders Foundation

2019-05-16 22:00:00 | Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Corcept, Mobile TeleSystems, Healthcare Services, and American Renal and Encourages Investors to Contact the Firm

2019-05-13 15:00:00 | CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action

2019-05-13 10:43:00 | DEADLINE MONDAY REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-05-13 09:30:53 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, HCSG, BA and NOK

2019-05-13 09:21:16 | DEADLINE TODAY: Rosen Law Firm Reminds Corcept Therapeutics Incorporated Investors of Important May 13th Deadline in Securities Class Action Lawsuit - CORT

2019-05-12 10:20:00 | INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In NIO, CORT, HCSG or FCHS To Contact The Firm

2019-05-10 17:30:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, FSNN and BSX

2019-05-10 15:50:00 | 3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-05-10 14:25:00 | CLASS ACTION UPDATE for CORT, FSNN and MWA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-05-10 12:00:00 | DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-05-10 11:56:38 | Corcept Therapeutics Incorporated CORT Q1 2019 Earnings Call Transcript

2019-05-10 07:19:47 | Edited Transcript of CORT earnings conference call or presentation 9-May-19 9:00pm GMT

2019-05-09 19:25:11 | Corcept Therapeutics CORT Q1 Earnings Top Estimates

2019-05-09 18:23:01 | Corcept: 1Q Earnings Snapshot

2019-05-09 17:30:00 | CLASS ACTION UPDATE for CORT, NIO and BSX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-05-09 17:21:01 | Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corcept Therapeutics Incorporated